Int. Journal of Generic Drugs

Locum International Press.
Eight issues per year.

The International Journal of Generic Drugs publishes articles reviews and papers on all aspects of Generic and Innovative Drug Development from preformulation to aspects of regulatory strategy. Emphasis is placed on the US exposure of the Generic Drug Industry with special reference to the on-time development of ANDA submissions.

The Chemistry, Manufacture and Controls (CMC) section of NDA development cover hands-on nuts-and- bolts developmental issues that vary across the full drug development spectrum from documentation requirements, excipients specifications, development (pre-to-final) formulation, scale-up, analytical, cleaning and process validation protocols necessary for the entire drug development process.

The overall objective in generic / CMC drug development is to get the newly developed product to the market place on time. The Journal attempts to clarify and simplify development and regulatory issues to achieve this crucial objective.

Subscription Option Availability Print

$1499.00 - Print Edition (single-user airmail print edition worldwide)
$1699.00 - Corporate single license single pharma campus - (Print)
$1999.00 - Corporate multiple-user license - (print edition maximizes distribution and readership for multiple pharma campus).

Online Members	DOWNLOAD from this JOURNAL	USA	Euro	Pacific
	The Journal Title and Cover Page >
Join IAGIM	The Journal's Annual Calendar >
	List of Worldwide Subscription Agents >